Abstract
Familial Mediterranean Fever (FMF) is an auto-inflammatory disease characterized by periodic febrile episodes and sterile polyserositis and is extremely rare in Asian populations. Here, we report a case of FMF in a 61-year-old Japanese man who received a kidney transplant 31 years ago but had to re-start hemodialysis. Although kidney function had been stable since his initial transplant, serum creatinine levels had been increasing over the 2 years prior to his presentation at our hospital, and a periodic fever developed at the same time. Uremic symptoms were observed, and hemodialysis was re-started, prompting the patient to choose to undergo a second kidney transplantation. We re-checked his medical history and conducted further physical examinations. Given that the patient had previously undergone an operation for olecranon bursitis in which pericardial effusion had been identified, we considered the possibility of FMF and conducted a genetic test, which identified the E202Q heterozygous mutation in the MEFV gene. The patient was therefore diagnosed with variant FMF. To our knowledge, this is the first report of a Japanese kidney transplant recipient being diagnosed as an FMF variant. We describe the relationship of FMF and kidney transplantation in terms of prognosis and important points to note for treatment.
Similar content being viewed by others
References
Drenth JP, Van der Meer JW. Hereditary periodic fever. N Engl J Med. 2001;345:1748–57.
Migita K, Uehara R, Nakamura Y, et al. Familial Mediterranean fever in Japan. Medicine. 2012;91:337–43.
Ozqocmen S, Akqul O. Anti-TNF agents in familial Mediterranean fever: report of three cases and review of the literature. Mod Rheumatol. 2011;21:684–90.
Seyahi E, Ozdogan H, Celik S, et al. Treatment options in colchicine resistant familial Mediterranean fever patients: thalidomide and etanercept as adjunctive agents. Clin Exp Rheumatol. 2006;24:S99–103.
Calligaris L, Marchetti F, Tommasini A, et al. The efficacy of anakinra in an adolescent with colchicine-resistant familial Mediterranean fever. Eur J Pediatr. 2007;167:695–6.
Ben-Zvi I, Danilesko I, Yahalom G, et al. Risk factors for amyloidosis and impact of kidney transplantation on the course of familial Mediterranean fever. Isr Med Assoc J. 2012;14:221–4.
Erdem E, Karatas A, Kaya C, et al. Renal transplantation in patients with familial Mediterranean fever. Clin Rheumatol. 2012;31:1183–6.
Erek E, Suleymanlar G, Serdengecti K. Nephrology, dialysis and transplantation in Turkey. Nephrol Dial Transplant. 2002;17:2087–93.
Ensari C, Ensari A, Tumer N, et al. Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients. Nephrol Dial Transplant. 2005;20:1721–5.
Nakai S, Watanabe Y, Masakane I, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2011) from Japanese Society for Dialysis therapy. Ther Apher Dial. 2013;17:567–611.
Cambier JF, Castanares-Zapatero D, Jacquet L, et al. The case: multiple-organ in a dialysis patient with pericarditis. Kidney Int. 2011;80:787–8.
Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis Rheumatol. 1997;40:1879–85.
Acknowledgments
The authors thank Dr. Kiyoshi Migita (Clinical Research Center, NHO Nagasaki Medical Center) for examining the sequence of the MEFV gene.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors have no conflicts of interest to declare.
About this article
Cite this article
Yazawa, M., Tsujita, M., Goto, N. et al. Familial Mediterranean Fever developing in a Japanese kidney transplant recipient. CEN Case Rep 5, 43–47 (2016). https://doi.org/10.1007/s13730-015-0188-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13730-015-0188-8